hotspot -WSS

hotspot

author：knowledge 2025-08-11 11:42:20 - browse：28

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： The CDC's new social media misinformation war

focus

WSS

Cancer diagnosis changes perspective doctor, former hospital CEO

Adopting new red light myopia treatments may be short

First transplant of an entire human eye performed

How state and local governments are sidelining science

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Global cancer cases to surge 77% by 2050, WHO report says

hotspot

hotspot

knowledge

Affirmative action in medical school literally saved lives

Cano Health’s bankruptcy is a warning for Medicare Advantage

In age of alternative facts, a scholarly course on calling out crap

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Continuity nursing helped my family in our darkest PICU moments

Weight loss drugs should be covered by insurers, AMA says

Sports medicine is finally prioritizing gender equality

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Guidelines to prevent youth baseball injuries need more muscle

AI gets buy

leisure time

Problems with a popular proposal to regulate AI in health care

What health policies could hitch a ride on a spending bill?

Study suggests Covid rebound is far more common with Paxlovid than without

A single Democrat is willing to weaken Medicare negotiation power

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Padmanee Sharma of MD Anderson at center of lawsuit over credit

focus

explore

leisure time

focus